Study on Hemodynamic Changes on Multi-slice CT Perfusion Imaging in Primary Hepatocellular Carcinoma with Portal Vein Tumor Thrombus
Xiwen Wang
Abstract
Xiwen Wang
Abstract
[Purpose]To study hemodynamic changes on multi-slice CT (MSCT) perfusion imaging in primary hepatocellular carcinoma(HCC) with portal vein tumor thrombus (PVTT). [Methods] MSCT perfusion imaging was performed with a spiral CT scanner in 84 patients. Total hepatic blood flow(HBF), hepatic blood volume(HBV), mean transit time(MTT), permeability surface (PS) and hepatic arterial fraction (HAF) were measured. [Results] Compared with the positive control group B, the HBF and HAF of the tumor tissues in test group A increased significantly [(435.31±89.21)ml/(100g·min) vs.(365.71±67.38)ml/(100g·min), (0.87±0.26) vs.(0.72±0.23)], and also the HBV and HAF of the PVTT in test group A [(44.72±11.62)ml/100g vs.(30.38±28.61)ml/100g, (0.93±0.14) vs.(0.72±0.23)] (P0.05). However, the MTT of the tumor tissues in test group A was shorter significantly than that in positive control group B [(5.73±4.28)s vs.(8.22±3.51)s, P0.05]. Compared with the negative control group C, the HBF, HBV and HAF of the hyperperfusion abnormality tissues in test group A increased significantly. [Conclusion] MSCT perfusion parameters may reflect the hemodynamic change of HCC with PVTT.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
[Purpose]To study hemodynamic changes on multi-slice CT (MSCT) perfusion imaging in primary hepatocellular carcinoma(HCC) with portal vein tumor thrombus (PVTT). [Methods] MSCT perfusion imaging was performed with a spiral CT scanner in 84 patients. Total hepatic blood flow(HBF), hepatic blood volume(HBV), mean transit time(MTT), permeability surface (PS) and hepatic arterial fraction (HAF) were measured. [Results] Compared with the positive control group B, the HBF and HAF of the tumor tissues in test group A increased significantly [(435.31±89.21)ml/(100g·min) vs.(365.71±67.38)ml/(100g·min), (0.87±0.26) vs.(0.72±0.23)], and also the HBV and HAF of the PVTT in test group A [(44.72±11.62)ml/100g vs.(30.38±28.61)ml/100g, (0.93±0.14) vs.(0.72±0.23)] (P0.05). However, the MTT of the tumor tissues in test group A was shorter significantly than that in positive control group B [(5.73±4.28)s vs.(8.22±3.51)s, P0.05]. Compared with the negative control group C, the HBF, HBV and HAF of the hyperperfusion abnormality tissues in test group A increased significantly. [Conclusion] MSCT perfusion parameters may reflect the hemodynamic change of HCC with PVTT.
Key concepts: Medicine, Hepatocellular carcinoma, Perfusion, Hemodynamics, Perfusion scanning, Thrombus, Blood flow, Nuclear medicine